Tokyo Gateway · Medical Platform

Turn Japan medical excellence into a global platform.

The medical team brings Japan-grade clinical trust and regenerative medicine ambition. AIKOL Hubs brings the cross-border market engine: positioning, patient pathways, partner access, digital execution, AI workflows and KOL-led credibility.

Build With AIKOL Meet the Team

Hayashi clinic building and Japan medical platform exterior.

Japan medical baseClinical trust before everything else.

Medical laboratory and cell science visual.

CPC/CDMOQuality-led infrastructure.

2026Tokyo Global Medical Clinic is planned for autumn 2026, with a broader regenerative medicine platform being prepared in Tokyo.

Team Members

Medical leadership with platform execution.

The platform brings together clinical credibility, medical institution operations, regenerative medicine planning, healthcare management, finance and M&A experience.

Dr. Yasuto Hayashi · 林靖人医师

Physician, neurosurgery specialist and medical institution founder.

A Nippon Medical School graduate with long clinical experience in neurosurgery and internal medicine, Dr. Hayashi has founded and operated medical institutions in Japan and is preparing a major Tokyo regenerative medicine clinic platform.

1994 · Graduated from Nippon Medical School.
1995–2004 · Neurosurgery, Nippon Medical School Hospital.
2002 · Certified neurosurgery specialist.
2005 · Opened Hayashi Neurosurgery and Internal Medicine Clinic.
2006 · Established Medical Corporation Seiwakai as chairperson.
2015 · Established Hayashi Neurosurgical Medical Clinic.
Autumn 2026 · Tokyo Global Medical Clinic planned.

Executive medical operations visual for Masaru Kawabata.

Masaru Kawabata · 川畑优

Medical operations, finance and regenerative platform commercialisation.

Mr. Kawabata brings a clinical laboratory technologist background, MBA training and deep experience across medical corporation improvement, financing, M&A support and healthcare project planning.

1997 · Kyoto University medical technology program.
2008 · Doshisha University, Faculty of Commerce.
2010 · Doshisha MBA.
1997–2012 · Tokushukai Medical Corporation.
2012–2018 · Pacific Consultants Co., Ltd.
2018–present · Representative Director, Zero Phoenix Consulting Japan.
2026 · Participating in Tokyo Global Medical Clinic planning.

Regenerative Medicine

Personalised care inside a compliant medical framework.

The platform is built on Japan’s medical safety culture, combining consultation, assessment and physician judgement before any care pathway is considered.

High-end clinical laboratory technology visual.

Medical safetyMeasured, compliant and doctor-led.

Service directions

Autologous adipose-derived stem-cell related care pathways
Skin regenerative medicine consultations
Joint-related regenerative medicine support
Growth-factor related services
Cell banking and long-term health management
Anti-ageing and preventive health support

Compliance position

The platform does not promise cure, guaranteed results or exaggerated outcomes. All medical activity is performed independently by licensed medical institutions and physicians under applicable Japanese laws and clinical judgement.

Doctor judgementPatient assessmentHealth managementClear pathway

CPC/CDMO

From clinic concept to regenerative medicine infrastructure.

CPC/CDMO capability turns the platform from a single clinic story into a scalable industry base for cell processing, quality control, standardised manufacturing and technical cooperation.

Core capabilities

Cell processing facility planning and operation
Standardised cell culture workflows
Quality management system design
GCTP/GMP-oriented operating management
Cell processing, testing and data management
Regenerative medicine manufacturing collaboration
Third-party manufacturing and technical service potential
Government grant and industry-support applications

Government and industry support

The project will explore Japan-based support opportunities around regenerative medicine manufacturing, automated culture, quality systems, CPC/CDMO infrastructure and domestic manufacturing capability.

Relevant pathways may include AMED, the Ministry of Economy, Trade and Industry, and local government industry-support programs where eligibility and timing align.

Medical Tourism

A safer, clearer Japan pathway for global patients.

Designed for overseas high-net-worth patients, families, executives and international partner institutions that need medical clarity, privacy, translation and coordinated travel support.

Private coordinationMultilingual supportHotel and transportFollow-up care

Online Enquiry

Tell us who you are, where you are based and what you need.

Medical Review

We organise the request for appropriate medical review.

Travel Planning

Japan arrival, hotel, transport and language support are coordinated.

Doctor Consultation

A licensed medical institution confirms suitability and next steps.

Treatment / Health Check

Services are delivered under the applicable medical framework.

Follow-up

Ongoing care communication and long-term health management can be arranged.

Private delegation and partner option

The platform welcomes discussion with hospitals, medical tourism agencies, investors, research groups, government bodies and CDMO partners who want a Japan-based regenerative medicine pathway with operational discipline.

Overseas preliminary consultation and request sorting.
Doctor consultation scheduling and translation support.
Arrival reception, hotel, transport and payment coordination.
Health check, regenerative consultation and long-term follow-up planning.

Platform Position

The right medical founder should not commercialise alone.

AIKOL Hubs is the partner layer for serious medical founders who already have clinical credibility, but need market architecture, international access, content, partner routing and execution to turn that credibility into qualified demand.

Discuss Founder Partnership Reference Clinic Site

Commercialise with restraint

AIKOL Hubs helps medical founders present serious capability in a way that feels premium, compliant and investable.

Open cross-border demand

We help shape the pathway for patients, agencies, investors and institutional partners across Australia, China and Japan.

Turn trust into a platform

We connect clinical credibility, content, partner routing and operational follow-up into a market-building system.

3 assets methodology

AIKOL Hubs compounds digital infrastructure, content engines and operational pathways so medical founders can turn expertise into a scalable market platform.

3-country operator network

Our teams across Australia, China and Japan help founders open cross-border conversations, localise trust and move faster between patients, partners and capital.

Marketing from strategy to execution

We sharpen the offer, build the funnel, create the content and execute campaigns that convert credibility into qualified demand.

AI + KOL leverage

We use AI and key opinion leaders to multiply authority, personalise outreach and create market momentum founders cannot build alone.

Contact

Start with the right conversation.

Submit a patient, partner, investor, agency, government, research or CDMO enquiry, or speak with AIKOL Hubs about building the cross-border market layer around a serious Japan medical platform.

This page is for platform introduction and enquiry routing only. It does not provide medical advice, diagnosis or treatment. Medical suitability must be assessed by licensed physicians and institutions.